March 4, 2019 Price forecast | 2 weeks: 0.66% | 1 month: 2.02% | 3 months: 4.60%


VNDA stock forecast

Our latest prediction for Vanda Pharmaceuticals, Inc.'s stock price was made on the March 4, 2019 when the stock price was at 19.84$.

In the short term (2weeks), VNDA's stock price should outperform the market by 0.66%. During that period the price should oscillate between -7.41% and +9.50%.

In the medium term (3months), VNDA's stock price should outperform the market by 4.60%. During that period the price should oscillate between -16.66% and +24.87%.


About Vanda Pharmaceuticals, Inc.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

At the moment the company generates 219M USD in revenues.

On its last earning announcement, the company reported a profit of 2.23$ per share.

The book value per share is 4.80$

Vanda Pharmaceuticals, Inc. website


Three months stock forecastMarch 4, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
219M 89.10% 28M 12.60% 122M 2.23 - - 55M 4.80 51M -1M 50M